Português 
Español 
简体中文 
Unverified company
Facebook
Whatsapp
Twitter
Linkedin
About Us
Hybio is a hi-tech enterprise specialized in the R&D and manufacturing of diverse peptide products. Founded in 1998, after over decades of effort, we have grown to be one of the largest and most professional peptide pharmaceutical company in China. We were one of the first to enter the peptide pharmaceutical industry in China, and we are the only one that has a full range of peptide products and services, including peptide finished dosage products, peptide API products, and peptide CRO&CMO services. Our peptide finished dosage is mainly sold in the domestic market, but some of our peptide APIs have been supplied to customers all over the world. Hybio is a GMP-approved pharmaceutical company. Our GMP plant in Shenzhen is a facility occupying an area of more than 1,5000 sq.m. It has been often audited and inspected by local/national s-FDA authorities and by clients all over the world.
Main Markets
- Africa
- Asia
- North America
- Oceania
- South America
- Southwest Asia
- Western Europe
More about
Hybio Pharmaceutical Co., Ltd
500-1000
Employees
1
Sales volume (USD)
40%
% Export sales
1998
Year
Established
Business type
- Industry / Manufacturer
- Business Service
Keywords
- API Peptides
- FDF
- Liraglutide
- Semaglutide
- Terlipressin
- Atosiban Ver Mais
Contact and location
-
Andrew Li
-
+86 xxxxxxxx
-
深圳 / | China
Andrew Li
+86 xxxxxxxx
